ברקלוד 1 מ"ג

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

ENTECAVIR 1 MG

Disponible depuis:

BRISTOL, MYERS SQUIBB (ISRAEL) LIMITED

Code ATC:

J05AF10

forme pharmaceutique:

FILM COATED TABLETS

Mode d'administration:

PER OS

Fabriqué par:

BRISTOL MYERS SQUIBB SPA, ITALY

Groupe thérapeutique:

ENTECAVIR

indications thérapeutiques:

Baraclude is indicated for the treatment of chronic hepatitis B virus (HBV) infection in adults with compensated liver disease and evidence of active viral replication, and persistently elevated serum alanine aminotransferase (ALT) levels. This indication is based on clinical trial data in patients with HBeAg positive and HBeAg negative HBV infection, nucleoside naive patients and patients with lamivudine-refractory hepatitis B.Decompensated liver disease.

Date de l'autorisation:

2009-02-01